Outpatient Treatment of Uncomplicated Diverticulitis With Either Antibiotic or Nonantibiotic Treatment
NCT03146091 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33
Last updated 2022-08-18
Summary
Uncomplicated sigmoid diverticulitis is a common disease in Western countries. Traditional management includes inpatient administration of either oral or intravenous antibiotics with resumption of oral intake as symptoms improve. Recent literature has however questioned both inpatient and antibiotic treatment. Indeed, both inpatient and antibiotic treatment are associated with non-negligible risks to patients. The aim of this trial is to assess the feasibility of a randomized controlled trial designed to determine whether nonantibiotic treatment of uncomplicated diverticulitis is safe in the outpatient setting.
Conditions
- Uncomplicated Diverticular Disease
Interventions
- OTHER
-
Nonantibiotic treatment of uncomplicated diverticulitis
Patients randomized to this arm will be treated without antibiotics in the outpatient setting. Pain will be managed with appropriate analgesia as per protocol.
- OTHER
-
Antibiotic treatment of uncomplicated diverticulitis
Patients randomized to this arm will be treated with antibiotics in the outpatient setting. Pain will be managed with appropriate analgesia as per protocol.
Sponsors & Collaborators
-
Jewish General Hospital
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 90 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-05-20
- Primary Completion
- 2019-12-30
- Completion
- 2020-12-30
Countries
- Canada
Study Locations
More Related Trials
-
Secondary Prevention of Clostridioides Difficile Using Vancomycin
NCT06979609 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
FMT in Uncomplicated Diverticulitis
NCT05373784 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Comparison of Surgery and Medicine on the Impact of Diverticulitis (COSMID) Trial
NCT04095663 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Short-course Antibiotics vs Standard Course Antibiotics in Patients With Cholangitis
NCT05750966 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Intracolonic Vancomycin Therapy in Severe C. Diff Colitis
NCT01346059 ·Status: TERMINATED ·Phase: NA
-
Intestinal Lavage for the Treatment of Severe C. Difficile Infections
NCT02466698 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Loop Ileostomy With Colonic Lavage for Fulminant Clostridium Difficile Colitis
NCT02347280 ·Status: TERMINATED ·Phase: NA
-
Antibiotic Treatment Trial for Small Intestinal Bacterial Overgrowth
NCT02458781 ·Status: UNKNOWN ·Phase: PHASE4
-
Multi-Centre Trial of Fresh vs. Frozen-and-Thawed FMT for Recurrent CDI
NCT01398969 ·Status: COMPLETED ·Phase: PHASE2
-
Antibiotics as an Adjuvant in Patients With Acute Severe Ulcerative Colitis
NCT03794765 ·Status: COMPLETED ·Phase: PHASE2
-
Multicentre Blinded Comparison of Lyophilized Sterile Fecal Filtrate to Lyophilized Fecal Microbiota Transplant in Recurrent Clostridioides Difficile Infection
NCT03806803 ·Status: COMPLETED ·Phase: PHASE2
-
Rifamycin SV-MMX® 400 mg b.i.d. vs. Rifamycin SV-MMX® 600 mg t.i.d. vs. Placebo in Acute Uncomplicated Diverticulitis
NCT01847664 ·Status: COMPLETED ·Phase: PHASE2
-
Trial of Antimicrobials Versus Placebo in Addition to Fecal Transplant Therapy in Ulcerative Colitis
NCT02606032 ·Status: COMPLETED ·Phase: PHASE2
-
Vancomycin Taper to Prevent Recurrent Clostridioides Difficile
NCT07328971 ·Status: RECRUITING ·Phase: PHASE3
-
Antibiotics for the Treatment of Ulcerative Colitis
NCT00355602 ·Status: COMPLETED ·Phase: NA
-
Fecal Microbiota Transplantation by Colonoscopy for Recurrent C. Difficile Infection
NCT02148601 ·Status: COMPLETED ·Phase: PHASE2
-
C Difficile Near-patient Diagnostics
NCT03857464 ·Status: COMPLETED ·Phase: NA
-
Lyophilized Fecal Transplant vs Lyophilized Fecal Filtrate in Recurrent C Diff Infection
NCT03353506 ·Status: COMPLETED ·Phase: PHASE2
-
Metagenomic and Metabolomic Reconstitution of Gut Microbiota After Broad Spectrum Antibiotic Therapy
NCT04171466 ·Status: COMPLETED ·Phase: NA
-
Effectiveness of Isolating Clostridium Difficile Asymptomatic Carriers on the Incidence of Infections
NCT03223415 ·Status: COMPLETED ·Phase: NA
-
Response of Clostridium Difficile Infection to Metronidazole Therapy
NCT00304369 ·Status: COMPLETED
-
Probiotics Administration Via Colonoscopic Spray and Oral Administration in CDAD Patients
NCT05770726 ·Status: RECRUITING ·Phase: NA
-
Rifaximin Delayed Release for the Prevention of Recurrent Acute Diverticulitis and Diverticular Complications.
NCT03469050 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
AssessmeNT of the Incidence of Clostridium Difficile Infections in Hospitalized Patients on Antibiotic TrEatment
NCT02896244 ·Status: COMPLETED
-
Small Bowel Transit Time in Clostridium Difficile Colitis
NCT01309750 ·Status: TERMINATED